LLY stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
Ricks David A2023/03/31SVP and Pres, Lilly Bio-Meds170728-408462023-03-3100000594780000059478129882
-
Ricks David A2023/03/30SVP and Pres, Lilly Bio-Meds170728-408462023-03-3000000594780000059478129882
-
Hedley Mary Lynne2023/03/29512023-03-290000059478000005947851
-
Zakrowski Donald A2023/03/28Chief Accounting Officer46594-272002023-03-280000059478000005947819394
-
Hedley Mary Lynne2023/03/27512023-03-270000059478000005947851
-
Hedley Mary Lynne2023/03/26512023-03-260000059478000005947851
-
LECHLEITER JOHN C2023/03/25President and COO155390-766662023-03-250000059478000005947878724
-
Skovronsky Daniel2023/03/24SVP, CSO, and Pres. LRL1105572023-03-2400000594780000059478110557
-
Hedley Mary Lynne2023/03/23512023-03-230000059478000005947851
-
Hedley Mary Lynne2023/03/22512023-03-220000059478000005947851
Related News

BlackRock (NYSE:BLK) Stock: A Resilient Investment at $747.91 With Promising Growth Ahead
TradingNEWS Archive
11.05.25

Can NASDAQ:BIDU Surge Above $200? How Will AI and Robotaxi Businesses Impact Baidu’s Future Price?
TradingNEWS Archive
10.05.25

Is NASDAQ: INTC Ready for a Strong Recovery in 2025?
TradingNEWS Archive
10.05.25

Shell’s Bold Move: Can a Potential BP Acquisition Propel NYSE:SHEL to New Heights Amid $60 Brent Prices?
TradingNEWS Archive
09.05.25